Frequency of CTLA-4 gene CT60 polymorphism may not be affected by vitamin D receptor gene Bsm I polymorphism or HLA DR9 in autoimmune-related type 1 diabetes in the Japanese

Annals of the New York Academy of Sciences

Volumn 1079, Issue , 2006, Pages 251-256

  Kanazawa, Yasuhiko ^a   Motohashi, Yoshiko ^b   Yamada, Satoru ^c   Oikawa, Yoichi ^a   Shigihara, Toshikatsu ^a   Okubo, Yoshiaki ^a   Maruyama, Taro ^d   Shimada, Akira ^a  

^a KEIO UNIVERSITY   (Japan)

^b Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^c KITASATO INSTITUTE HOSPITAL   (Japan)

^d SAITAMA SOCIAL INSURANCE HOSPITAL   (Japan)

Author keywords

CTLA 4; HLA; Type 1 diabetes; Vitamin D receptor

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN; HLA DR9 ANTIGEN; VITAMIN D RECEPTOR;

ADULT; ALLELE; AUTOIMMUNE DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MAJOR CLINICAL STUDY; MALE; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33845711184     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1375.038     Document Type: Conference Paper

References (8)

1. UEDA, H., J.M.M. HOWSON, J.A. TODD, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 508-511.
2. RIGBY, W.F., S. DENOME & M.W. FANGER. 1987. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J. Clin. Invest. 79: 1659-1664.
3. PROVVEDINI, D.M. & S.C. MANOLAGAS. 1989. 1Alpha, 25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J. Clin. Endocrinol. Metab. 68: 774-779.
4. MOTOHASHI, Y., S. YAMADA, T. YANAGAWA, et al. 2003. Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J. Clin. Endocrinol. Metab. 88: 3137-3140.
5. ITOH, A., A. SHIMADA, et al. 2004. GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA, DR9. Ann. N. Y. Acad. Sci. 1037: 33-40.
6. KASUGA, A., Y. OZAWA, T. MARUYAMA, et al. 1997. Autoantibody against ICA 512 did not improve test sensitivity for slowly progressive IDDM in adults. Diabetes Care 20: 679-680.
7. MARUYAMA, T., A. KASUGA, Y. OZAWA, et al. 1997. Glutamic acid decarboxylase 65 (GAD 65) antibodies and insulin autoantibodies in Japanese patients with non-insulin dependent diabetes mellitus. Endocr. J. 44: 43-51.
8. MARUYAMA, T., A. SHIMADA, A. KASUGA, et al. 1994. Analysis of MHC class II antigens in Japanese, IDDM by a novel HLA-typing method, hybridization protection assay. Diabetes Res. Clin. Pract. 23: 77-84.